Sitafloxacin clinical trials
How each study uses sitafloxacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the sitafloxacin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2025 (3)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2016 | 1 |
| 2022 | 2 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 6
Shenzhen Third People's Hospital (2) · Daiichi Sankyo (1) · Beijing Chest Hospital (1) · First Affiliated Hospital of Zhejiang University (1) · Khon Kaen University (1) · Mahidol University (1)
Often tested with
Tested in the same studies.
Bedaquiline (2) · Linezolid (2) · Pyrazinamide (2) · Rifapentine (1)
Studies
Open first, then newest update. How each study uses sitafloxacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A PAN-USR TB Multi-Center TrialRecruitingPhase 3Shenzhen Third People's HospitalNCT06905522Written as Sitafloxacin (S)
- Ultra-Short Regimen for Elderly DS-TBNot yet recruitingPhase 3Shenzhen Third People's HospitalNCT07076225Written as Sitafloxacin (S)
- Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus DiseaseEnrolling by invitationPhase 2Beijing Chest HospitalNCT06809413Written as Sitafloxacin
- Sitafloxacin-containing Regimens for Shortening Tuberculosis TreatmentNot yet recruitingPhase 3First Affiliated Hospital of Zhejiang UniversityNCT05454345Written as Sitafloxacin
- A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseCompletedPhase 4Daiichi SankyoNCT05400369Written as Sitafloxacin
- Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation PatientsStatus unknownPhase 2/3Khon Kaen UniversityNCT02729116Written as Sitafloxacin
- Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia ColiStatus unknownPhase 2Mahidol UniversityNCT02537847Written as Sitafloxacin
Codes
What other systems call sitafloxacin · ClinicalTrials.gg INT003652
- MeSH (NLM) C076246sitafloxacinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 9TD681796GSITAFLOXACINConfirmed FDA, NLM, Wikidata
- Wikidata Q72507631Sitafloxacin hydrate (2:3)Confirmed FDA, NLM, Wikidata
- NCI Thesaurus C76922SitafloxacinOne source FDA
- DrugBank DB13261One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C076246 | sitafloxacin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 9TD681796G | SITAFLOXACIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q72507631 | Sitafloxacin hydrate (2:3) | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76922 | Sitafloxacin | One source FDA |
| DrugBank | DB13261 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.